Inspiremd (NSPR)CEO bought ~$25K

~$25K

Approx. value · 21K sh @ $1.20

3.56M

Holds after · shares reported

Traded

May 12, 2026

Filed

May 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 27, 2025InsiderOfficer sold ~$10K of NSPR shares in the open market
2. Jan 28, 2025InsiderOfficer sold ~$6.5K of NSPR shares in the open market
3. Jan 29, 2025InsiderOfficer sold ~$9K of NSPR shares in the open market
4. Jan 30, 2025InsiderOfficer sold ~$6.2K of NSPR shares in the open market
5. Jan 31, 2025InsiderOfficer sold ~$25K of NSPR shares in the open market
6. Feb 3, 2025InsiderOfficer sold ~$18K of NSPR shares in the open market
7. Feb 4, 2025InsiderOfficer sold ~$13K of NSPR shares in the open market
8. Feb 25, 2025InsiderOfficer sold ~$37K of NSPR shares in the open market
9. May 23, 2025InsiderOfficer sold ~$6.2K of NSPR shares in the open market
10. May 27, 2025InsiderOfficer sold ~$3.9K of NSPR shares in the open market
11. May 29, 2025InsiderOfficer sold ~$9.4K of NSPR shares in the open market
12. May 30, 2025InsiderOfficer sold ~$18K of NSPR shares in the open market
13. Feb 2, 2026InsiderOfficer sold ~$4.7K of NSPR shares in the open market
14. Mar 18, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
15. Apr 3, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
16. May 4, 2026Company filing · Form 8-K · ResultsReported its results
17. May 6, 2026Insider · 2 peopleInsiders: 2 purchases (~$20K)
18. May 7, 2026Insider · 3 peopleInsiders: 3 purchases (~$198K)
19. May 8, 2026Insider · Named in an 8-K 12 days laterDirector purchased ~$76K of NSPR shares in the open market
20. May 11, 2026Insider · Named in an 8-K 9 days laterDirector purchased ~$12K of NSPR shares in the open market
21. May 12, 2026 · this disclosureInsider · 4 insiders in a week, 7th time since 2012CEO purchased ~$25K of NSPR shares in the open market

What came next

1. May 13, 2026Insider · Named in an 8-K 7 days laterDirector purchased ~$12K of NSPR shares in the open market
2. May 14, 2026Insider · Named in an 8-K 6 days laterDirector purchased ~$5.8K of NSPR shares in the open market
3. May 19, 2026InsiderOfficer sold ~$23K of NSPR shares in the open market
4. May 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 20, 2026, Mr. Paul Stuka notified InspireMD, Inc. (the “Company”) of his decision to not seek reelection as a Class I director of the Board of Directors of the Company (the “Board”) at the Company’s 2027 Annual Meeting of Stockholders (the “2027 Annual Meeting”) and to retire from the Board.”
5. May 27, 2026Insider · Named in an 8-K 7 days earlierDirector purchased ~$18K of NSPR shares in the open market
6. Jun 3, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
7. Jun 26, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 26, 2026, Mr. Raymond W. Cohen, a Class III member of the board of directors (the “Board”) of InspireMD, Inc. (the “Company”), a member of the Audit Committee of the Board and a member of the Compensation Committee of the Board, tendered his resignation from the Board, effective July 1, 2026.”
8. Jul 17, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On July 17, 2026, InspireMD, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of…”
9. Jul 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 23, 2026, InspireMD, Inc. (the “Company”) provided notice to Shane Gleason, the Company’s Chief Commercial Officer, that his position has been eliminated.”
10. Aug 17, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Inspiremd

OQRO holds no insider, Congress, fund or contract record for Inspiremd dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NSPR page.

Other recent filings by Marvin Slosman, CEO and President

• SEC Form 4 at Inspiremd (NSPR)Aug 1, 2025

The full history of Marvin Slosman, CEO and President is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Inspiremd

• SEC Form 4May 29, 2026
• SEC Form 4May 21, 2026
• SEC Form 4May 21, 2026
• SEC Form 4May 21, 2026
• SEC Form 4May 21, 2026
• SEC Form 4May 21, 2026

Everything OQRO holds on this company is on its NSPR page.